FIRST AMENDED ORDER GRANTING PLAINTIFFS’ MOTION FOR PRELIMINARY INJUNCTION AND DENYING DEFENDANT ALLEN’S MOTION TO DISMISS PLAINTIFFS’ COMPLAINT
This mаtter comes before the Court on Plaintiffs’ Motion for Preliminary Injunction (doc. # 2) and Defendant Michael K. Allen’s Motion To Dismiss This Action Under Federal Rule 12(B) (doc. # 28). Plaintiffs Planned Parenthood Cincinnati Region, Planned Parenthood of Central Ohio, Planned Parenthood of Greater Cleveland, and Preterm (“Planned' Parenthood”) filed both the original Complaint (doc. # 1) and the Motion for Preliminary Injunction (doc. #2) on August 2, 2004. For the reasons set fоrth below, the Court GRANTS Plaintiffs’ Motion.
I. BACKGROUND
Plaintiffs Planned Parenthood, Dr. So-gor, and Dr. Kade (collectively, “Plaintiffs”), brought this action challenging the constitutionality of Ohio’s recently enacted H.B. 126 (“the Act”), which is scheduled to take effect on September 23, 2004. The Act regulates the use of mifepristone, commonly known as RU-486, which is a drug used for medical abortion. Specifically, the Act provides:
No person shall knowingly give, sell, dispense, administer, otherwise provide, or prescribe RU-486 (mifepristone) to another for the purpose of inducing an abortion ... unless the person ... is a physician, the physician satisfies all the criteria established by federal law that a physician must satisfy in order to provide RU-486 (mifepristone) for inducing abortions, and the physician provides the RU-486 (mifepristone) to the other person for the purpose of inducing an abortiоn in accordance with all provisions of federal law that govern the use of RU-486 (mifepristone) for inducing abortions.
§ 2919.123(A) (emphasis added).
The Act defines “federal law” as, “any law, rule, or regulation of the United States or any drug approval letter of the food and drug administration of the United States that governs or regulates the use of RU-486 (mifepristone) for the purpose of inducing abortions.” See § 2919.123(F). Violators of the Act are deemed “guilty of unlawful distribution of an abortion-inducing drug, a felony of the fourth degreе,” and repeat offenders are guilty of a felony in the third degree. See § 2919.123(E). Further, the Act provides that offenders who are doctors are “subject to sanctioning as provided by law by the regulatory or licensing board or agency that has the administrative authority to suspend or revoke the offender’s professional license.” Id. Finally, the Act requires the state medical board to revoke, suspend, reprimand, or refusе to grant a certificate to any doctor who enters a plea of guilty or is found guilty of violating any state law regulating the distribution of any drug. See § 4731.22(B)(3). Section 4731.22(B)(3) clearly applies to doctors found guilty of violating Section 2919.123(A) for unlawfully prescribing mifepristone.
Plaintiffs moved for a preliminary injunction “restraining defendants, their employees, agents, and successors, and all others acting in concert or participation with thеm, from enforcing the provisions of H.B. 126” (doc. #2, at 1). Plaintiffs
II. JURISDICTION AND STANDING
The Court conducted a hearing on the Motion for Preliminary Injunction on September 13 аnd 14, 2004. Following Opening Statements on September 13, 2004, the Court expressed its concerns about Planned Parenthood’s standing. On the morning of September 14, 2004, before the Court convened, Plaintiffs filed an Amended Complaint (doc. # 18) adding Dr. Lász-ló Sogor and Dr. Roslyn Kade (“Plaintiff Physicians”) as Plaintiffs. On September 14, 2004, Defendants requested a continuance of the hearing, arguing that: 1) because the Amended Complaint added plaintiffs, it rendered the Motion fоr Preliminary Injunction before the Court “stale” such that there was no pending Motion for Preliminary Injunction before the Court; and 2) because Planned Parenthood filed the Amended Complaint during the hearing and Defendants had not had time to read it or respond to it, Defendants were thereby prejudiced.
The Court held that the Amended Complaint related back to the time of the filing of the original Complaint, and that the Motion for Preliminary Injunction was therefore not stale. 2 The Court then proceeded with the hearing. Consequently, the Court will consider the Amended Complaint to be the relevant complaint for purposes of the Motion for Preliminary Injunction.
Generally, this Court has federal question jurisdiction to consider a case, such as this one, where Plaintiffs challenge an alleged deprivation of a Constitutional right by a State law.
See
28 U.S.C. §§ 1331, 1343(a)(3), аnd 1343(a)(4). Nevertheless, this Court would lack jurisdiction to proceed if, as Defendants contend, Plaintiffs lack standing to pursue this case.
See Lujan v. Defenders of Wildlife,
Defendants cite
Women’s Medical Prof Corp. v. Taft,
Defendаnts also contend that in order to establish standing, each Plaintiff must submit factual evidence for the Court to examine to determine if each of the Plaintiffs has met the standing requirements. Defendants would be correct if the Court were determining standing for the purposes of a final judgment on the merits.
See Lujan,
Standing involves two levels of inquiry: 1) whether the plaintiff has shown that a “case or controversy” exists, which can be shown by proving actual injury or injury in fact likely to be redressed by a favorable decision; and 2) whether the plaintiff is the proper proponent of the rights on which the action is based.
See Planned Parenthood Ass’n of Cincinnati, Inc. v. City of Cincinnati,
Dr. Kade is the medical director of Plaintiff Planned Parenthood Cincinnati Region and also has a private practice in Cincinnati. (Doc. # 18, ¶ 10.) As part of her duties at PPCR, Dr. Kade performs evidence-based medical abortions with mi-fepristone, which Defendants contend is prohibited by the Act. (Kade Affidavit, ¶¶ 6,8.) If, after the Act took effect, Dr. Kade continued her practice of providing evidence-based abortions using mifepri-stone, Defendants would have authority to prosecute her under the Act, and Dr. Kade has attested that she fears such prosecution.
(Id.
at ¶ 11.) Thus, Dr. Kade has clearly alleged a case or controversy with Defendants regarding an injury likely to be redressed by a favorable decision. Thus, because Dr. Kade faces a direct risk of enforced prosecution by Defendants under the Act, she has standing to bring a pre-enforcement challenge to the Act.
See WMPC v. Taft,
The Court therefore finds that Dr. Kade has both individual and third-party standing and thus dispenses with inquiry into the remaining Plaintiffs’ standing. Plaintiffs have made sufficient allegаtions in their complaint regarding standing both to withstand Allen’s Motion to Dismiss and to allow the Court to proceed to the merits of Plaintiffs’ Motion for Preliminary Injunction.
III. LEGAL STANDARD .
Federal Rule of Civil Procedure 65 authorizes the Court to grant a preliminary injunction. When deciding whether to issue a preliminary injunction, the Court considers four factors: “(1) whether the movant has a ‘strong’ likelihood of success on the merits; (2) whether the movant would otherwise suffer irreparable injury; (3) whether issuance of a preliminary injunction would cause substantial harm to others; and (4) whether the public interest would be served by issuance of a preliminary injunction.”
Leary v. Daeschner,
IV. ANALYSIS
Plaintiffs challenge the Act on the following grounds: “the Act is unconstitutionally vague; the Act violates their patients’ right to bodily integrity by compelling surgery in circumstances where a medical abortion [as opposed to surgical abortion] would otherwise be the desired or appropriate treatment; the Act lacks the constitutionally-mandated exception to allow otherwise restricted practices where they are necessary to preserve a woman’s life or health; and, the Act imposes an undue burden on their patients’ right to choose abortion by prohibiting a safe and common method of pre-viability abortion.” (Sеe doc. # 2, at 1.)
Plaintiffs allege that because of the former factors, Plaintiffs have a strong likelihood of success on the merits. Further, Plaintiffs allege that Planned Parenthood, Plaintiff Physicians, and their patients would face irreparable injury if the Act takes effect.
(Id.
at 18-19.) Specifically, Plaintiffs argue that because the Act is unconstitutionally vague, Plaintiff Physicians would be left to guess about whether they may legally providе medical abortions in certain instances.
(Id.
at 18.) Specifically, Plaintiffs state that Planned Parenthood and the Plaintiff Physicians have been providing medical abortions using an evidence-based protocol of mifepristone.
3
A. Strong Likelihood Of Success On The Merits
Though Plaintiffs bring four constitutional challenges to the Act, this motion can be resolved based upon just one of those: “the Act lacks the constitutionally-mandated exception to аllow otherwise restricted practices where they are necessary to preserve a woman’s life or health.”
(See
doc. #2, at 1.) As Plaintiffs note, a long line of Supreme Court authority mandates and reaffirms that the Due Process Clause of the Constitution requires that every statute regulating abortion include an exception for those situations where necessary, in appropriate medical judgment, to preserve the life and health of the mother.
See Stenberg v. Carhart,
Defendants’ arguments are misplaced. In
Carhart,
the Court considered a plaintiffs challenge to a Nebraska statute banning partial birth abortion. The Court held that the statute was unconstitutional both becausе it placed an undue burden on a woman’s right to a pre-viability abortion, and because it lacked a health exception (the Nebraska statute contained only a “mother’s life” exception). Like Defendants here, Nebraska argued that the statute did not require a health exception because there were alternative methods of abortion and the ban would create no risk to womens’ hеalth.
Id.
at 931,
A tenable reading of the former statement might imply, as Defendants argue, that a health exception is required оnly where it is evident that the banned or regulated method of abortion is necessary at times to preserve the health and safety of the mother. Significantly, however, even if the Court intended to modify the mandatory health exception, the Court clearly placed the burden of proof not, as Defendants desire, upon a plaintiff to prove that a health exception is necessary, but rather upon a defendant to show that a ban or regulation would never cause any risk to a mother’s health. Even if this Court were inclined to so read Stenberg— which it is not — Plaintiffs have still shown a strong likelihood of success on the merits because it is highly unlikely that Defendants will be able to prove that there are no circumstances in which the Act’s regulation of mifepristone would cause significant health risks. Plaintiffs have already presented expert medical testimony at the hearing that there are women who have medical conditions that render surgical abortion riskier than the evidence-based protocol for medical abortion, which Defendants argue is prohibited under the Act. (Tr. 9/13/04, Schaff test., 52:1-58:25; Tr. 9/14/04, Sogor tes., 23:15-25:5)
Also, despite the former analysis of Defendants’ argument, the Court finds that the appropriate reading of Carhart — and the one consistent with Supreme Court precedent — is that a health exception is always required. Indeed, the Carhart Court expressed the health exception requirement as an independent proposition in several other places in the opinion. While the scope of the necessary health exception is debated — not only by the parties here, but also by lower federal courts’ case law — this Court need not reach this question because the Act lacks any exception for the life or health of the mother. Consequently, Plaintiffs have a substantial likelihood 'of success on the merits that the Act violates the Due Process Clause and is unconstitutional.
B. Irreparable Injury
Because this Court has found that the Act threatens or impairs Plaintiffs’ patients’ constitutional right to Due Process,
C. Substantial Harm to Others
Because Plaintiffs have shown a substantial likelihood of success on the merits on the ground that the Act is unconstitutional, “no substantial harm to others can be said to inhere in its enjoinment.”
See Deja Vu of Nashville, Inc. v. Metropolitan Gov’t of Nashville,
D. Public Interest
“ ‘It is always in the public interest to prevent violation of a party’s constitutional rights.’ ”
Id.
at 400,
citing G & V Lounge, Inc. v. Michigan Liquor Control Comm’n,
V. CONCLUSION
Because Plaintiffs have demonstrated a strong likelihood of success on the merits regarding an alleged violation of their constitutional rights, the other factors to consider in granting a preliminary injunction automatically weigh in Plaintiffs’ favor. Because Plaintiffs have made sufficient allegations in their complaint to establish standing, and because all four factors to consider in issuing a preliminary injunction weigh heavily in favor of doing so, this Court DENIES Defendant Allen’s Motion To Dismiss (doc. # 28) and GRANTS Plaintiffs’ Motion for Preliminary Injunction (doc. #2). The Court hereby ENJOINS Defendants from enforcing the Act.
IT IS SO ORDERED.
Notes
. The Court has not had sufficient time to conduct a hearing on the Motion for Class Certification, as requested by both parties, before entering this Order. The Court in-tends to hold a hearing on the Motion for Class Certification following the entering of this Order and, if appropriate, to amend this Order consistent with its findings on class certification. As a provisional measure, the Court orders Defendant Attorney General Pe-tro to send notice of this Order to all 88 members of the proposed defendant class de-scribed in Plaintiffs' Motion for Class Certifi-cation within 48 hours of entry of this Order.
. The Court offered to extend the time for the hearing if Defendants requested more time to prepare for and respond to the Amended Complaint, which Defendants did not.
. Or in the case of Planned Parenthood of Central Ohio, intended to switch to an evi
. The evidence-bаsed protocol for medical abortion consists of a single oral dose of 200 mg of mifepristone followed by a single dose of .8 mg misoprostol administered vaginally, and is effective for medical abortion through at least 63 days after a woman's last menstrual period ("LMP”). The protocol for medical abortion that the FDA tested and on which it based its approval of mifepristone consisted of three oral doses of 200 mg of mifepristone followed by a single dose of .4 mg misoprostol also taken orally, through 49 days LMP.
